✦ LIBER ✦

Slowing chronic kidney disease progression: results of prospective clinical trials in adults

✍ Scribed by Thai Nguyen; Robert D. Toto

Publisher: Springer
Year: 2008
Tongue: English
Weight: 228 KB
Volume: 23
Category: Article
ISSN: 0931-041X
DOI: 10.1007/s00467-007-0737-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Study design and methods for a clinical

Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD)

✍ Satoshi Morita; Shunichi Fukuhara; Tadao Akizawa; Yasushi Asano; Kiyoshi Kurokaw 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 776 KB

Chemotherapy–radiotherapy association in

Chemotherapy–radiotherapy association in Hodgkin's Disease, clinical stages IA, II2A: Results of a prospective clinical trial with 166 patients

✍ Jean M. Andrieu; Bernard Montagnon; Bernard Asselain; Chantal Bayle-Weisgerber; 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 2 views

Combined chemotherapy-radiotherapy in ad

Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: Results of a prospective clinical trial with 70 stage IIIB-IV patients

✍ Christophe Fermé; Eric Lepage; Pauline Brice; Marie-Françoise D'Agay; Jean-Paul 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 1000 KB

Effectiveness of health-related quality-

Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians

✍ Jolie J. Gutteling; Anne-Sophie E. Darlington; Harry L. A. Janssen; Hugo J. Duiv 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 307 KB

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place

A prospective, double-blind, randomized,

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

✍ Bin Nie; Wan-Jun Cheng; Yan-Fang Li; Zheng Cao; Qing Yang; Ying-Xin Zhao; Yong-H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views